SANGINITA vs TRANSPEK: Stock Comparison
TRANSPEK is the larger company by market capitalisation. SANGINITA shows a lower P/E, while TRANSPEK shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
SANGINITA leads 1; TRANSPEK leads 9 of 11
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | SANGINITA | TRANSPEK |
|---|---|---|
| Sector | Chemicals | — |
| Industry | Specialty Chemicals | — |
Price
| Metric | SANGINITA | TRANSPEK |
|---|---|---|
| Live Price | ₹15.02 | ₹1,232.6 |
| Day Change | 3.23% | -2.36% |
| Volume | 2.53 L | 5,657 |
| 52-Week High | ₹15.87 | ₹1,447.9 |
| 52-Week Low | ₹9.26 | ₹952.3 |
| Distance from 52W High | -5.36% | -14.87% |
Valuation
| Metric | SANGINITA | TRANSPEK |
|---|---|---|
| Market Cap | ₹446 Cr | ₹698 Cr |
| P/E Ratio | 0x | 19.93x |
| P/B Ratio | 3.16x | 1.01x |
| EPS | ₹-1.9 | ₹15.98 |
| Book Value | ₹7.7 | ₹1,373.97 |
| Dividend Yield | 0% | 1.54% |
Growth
| Metric | SANGINITA | TRANSPEK |
|---|---|---|
| Revenue Growth (TTM YoY) | -40.99% | 0% |
| EPS Growth (TTM YoY) | 0% | 0% |
| Qtr Sales Growth | — | 1.92% |
| Qtr Profit Growth | — | 35.68% |
Profitability & Leverage
| Metric | SANGINITA | TRANSPEK |
|---|---|---|
| ROE | -20.85% | 5.95% |
| ROCE | -13.3% | 6.87% |
| Net Margin | -5.49% | 7.35% |
| Operating Margin | -4.42% | 11.15% |
| Debt to Equity | 0.26x | 0.06x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | SANGINITA | TRANSPEK |
|---|---|---|
| Promoter Holding | 0%▼ 25.4 pp | 57.27% |
| FII Holding | 0%▼ 0.19 pp | 0.02% |
| DII Holding | 0% | 1.05%▼ 0.55 pp |
| Public Holding | 32%▼ 42.41 pp | 41.66%▲ 0.75 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: SANGINITA and TRANSPEK.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.